Abstract
Importance: Virus infection has been widely described as one of the most common causes of myocarditis. However, less is known about the cardiac involvement as a complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Objective: To describe the presentation of acute myocardial inflammation in a patient with coronavirus disease 2019 (COVID-19) who recovered from the influenzalike syndrome and developed fatigue and signs and symptoms of heart failure a week after upper respiratory tract symptoms.
Design, setting, and participant: This case report describes an otherwise healthy 53-year-old woman who tested positive for COVID-19 and was admitted to the cardiac care unit in March 2020 for acute myopericarditis with systolic dysfunction, confirmed on cardiac magnetic resonance imaging, the week after onset of fever and dry cough due to COVID-19. The patient did not show any respiratory involvement during the clinical course.
Exposure: Cardiac involvement with COVID-19.
Main outcomes and measures: Detection of cardiac involvement with an increase in levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity troponin T, echocardiography changes, and diffuse biventricular myocardial edema and late gadolinium enhancement on cardiac magnetic resonance imaging.
Results: An otherwise healthy 53-year-old white woman presented to the emergency department with severe fatigue. She described fever and dry cough the week before. She was afebrile but hypotensive; electrocardiography showed diffuse ST elevation, and elevated high-sensitivity troponin T and NT-proBNP levels were detected. Findings on chest radiography were normal. There was no evidence of obstructive coronary disease on coronary angiography. Based on the COVID-19 outbreak, a nasopharyngeal swab was performed, with a positive result for SARS-CoV-2 on real-time reverse transcriptase-polymerase chain reaction assay. Cardiac magnetic resonance imaging showed increased wall thickness with diffuse biventricular hypokinesis, especially in the apical segments, and severe left ventricular dysfunction (left ventricular ejection fraction of 35%). Short tau inversion recovery and T2-mapping sequences showed marked biventricular myocardial interstitial edema, and there was also diffuse late gadolinium enhancement involving the entire biventricular wall. There was a circumferential pericardial effusion that was most notable around the right cardiac chambers. These findings were all consistent with acute myopericarditis. She was treated with dobutamine, antiviral drugs (lopinavir/ritonavir), steroids, chloroquine, and medical treatment for heart failure, with progressive clinical and instrumental stabilization.
Conclusions and relevance: This case highlights cardiac involvement as a complication associated with COVID-19, even without symptoms and signs of interstitial pneumonia.
Similar articles
-
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.PMID: 32169119 Free PMC article. Review.
-
[Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Dec;31(12):1538-1541. doi: 10.3760/cma.j.issn.2095-4352.2019.12.021.PMID: 32029045 Chinese. -
JAMA Ophthalmol. 2020 Mar 31:e201291. doi: 10.1001/jamaophthalmol.2020.1291. Online ahead of print.PMID: 32232433 Free PMC article.
-
Myopericarditis in children: elevated troponin I level does not predict outcome.
Pediatr Cardiol. 2012 Oct;33(7):1040-5. doi: 10.1007/s00246-012-0222-y. Epub 2012 Feb 10.PMID: 22322566 -
Features, Evaluation and Treatment Coronavirus (COVID-19).
2020 Mar 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.PMID: 32150360 Free Books & Documents. Review.
Πανελλήνια Ιατρική Εταιρεία Διευθυντών Καρδιολογίας 